Asset
CYTARABINE
Jazz Pharmaceuticals plc Common Stock (Ireland)
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02873338 | phase2 | completed | 2016-08-01 | 2019-06-01 | Jazz Pharmaceuticals | Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 209401 | NDA | JAZZ PHARMACEUTICALS THERAPEUTICS INC |
Marketed products (1)
- VYXEOS